Adagrasib
Showing 1 - 25 of 28
Healthy Adults Trial in Daytona Beach (Adagrasib, Eltrombopag + adagrasib)
Recruiting
- Healthy Adults
- Adagrasib
- Eltrombopag + adagrasib
-
Daytona Beach, FloridaFortrea Clinical Research Unit Daytona Beach (Labcorp Clinical R
Jun 29, 2023
Advanced Cancer, Metastatic Cancer, Malignant Tumor of Lung Trial in Santa Rosa (Adagrasib)
Recruiting
- Advanced Cancer
- +2 more
- Adagrasib
-
Santa Rosa, CaliforniaProvidence Medical Foundation
May 2, 2023
Lung Cancer, Gastro-intestinal Cancer Trial in Houston (Durvalumab, Adagrasib)
Not yet recruiting
- Lung Cancer
- Gastro-intestinal Cancer
- Durvalumab
- Adagrasib
-
Houston, TexasM D Anderson Cancer Center
May 9, 2023
Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)
Not yet recruiting
- Solid Tumor, Adult
- +4 more
- Adagrasib
- nab-Sirolimus
- (no location specified)
Apr 24, 2023
Metastatic Pancreatic Cancer Trial in Houston (MRTX849)
Not yet recruiting
- Metastatic Pancreatic Cancer
-
Houston, TexasM D Anderson Cancer Center
Nov 22, 2022
Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)
Not yet recruiting
- Advanced Solid Tumor
- Non-small Cell Lung Cancers
- Adagrasib
- Olaparib
-
Houston, TexasM D Anderson Cancer Center
Nov 15, 2023
Resectable NSCLC Trial (Adagrasib, Adagrasib/Nivolumab)
Not yet recruiting
- Resectable Non-Small Cell Lung Cancer
- Adagrasib
- Adagrasib/Nivolumab
- (no location specified)
Jul 21, 2022
Advanced NSCLC, Metastatic Lung Cancer Trial in East Syracuse, Cleveland, Bellingham (Adagrasib in combination with
Recruiting
- Advanced NSCLC
- Metastatic Lung Cancer
- Adagrasib in combination with pembrolizumab
- Pembrolizumab
-
East Syracuse, New York
- +2 more
Nov 28, 2022
Healthy Adults Trial in Dallas (Treatment A, Treatment B)
Not yet recruiting
- Healthy Adults
- Treatment A
- Treatment B
-
Dallas, TexasLabcorp Clinical Research Unit Inc
May 11, 2023
Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)
Recruiting
- Non Small Cell Lung Cancer
- +5 more
- avutometinib (VS-6766) and adagrasib
-
San Francisco, California
- +4 more
Dec 21, 2022
Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)
Not yet recruiting
- Colon Cancer
- Colorectal Cancer
- MRTX849
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2023
Advanced Cancer, Metastatic Cancer, Malignant Tumor Trial in Santa Rosa (adagrasib (MRTX849))
Available
- Advanced Cancer
- +2 more
- adagrasib (MRTX849)
-
Santa Rosa, CaliforniaProvidence Medical Group Santa Rosa - Cancer Center
Jan 19, 2022
NSCLC Stage IV, KRAS P.G12C Trial in Worldwide (Adagrasib)
Not yet recruiting
- NSCLC Stage IV
- KRAS P.G12C
- Adagrasib
-
Brussels, Belgium
- +26 more
Jan 3, 2023
Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)
Not yet recruiting
- Advanced Solid Tumors
- BMS-986466
- +2 more
-
Birmingham, Alabama
- +24 more
Aug 29, 2023
Advanced Cancer, Metastatic Cancer, Malignant Tumor of Colon Trial in United States (MRTX849, BI 1701963)
Active, not recruiting
- Advanced Cancer
- +4 more
- MRTX849
- BI 1701963
-
Saint Louis, Missouri
- +3 more
Apr 4, 2022
Advanced NSCLC, Metastatic NSCLC Trial in Worldwide (MRTX849 Monotherapy, MRTX849 in Combination with Pembrolizumab)
Recruiting
- Advanced Non-Small Cell Lung Cancer
- Metastatic Non-Small Cell Lung Cancer
- MRTX849 Monotherapy
- +2 more
-
Prescott Valley, Arizona
- +134 more
Jan 25, 2023
Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- +2 more
- (no location specified)
Aug 11, 2023
Studying Pathways of Resistance in KRAS-driven Cancers
Not yet recruiting
- KRAS P.G12C
- FoundationOne® Liquid CDx
- (no location specified)
Mar 9, 2022